There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes.

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...

However, the drugs have their limits -- such as weight-loss plateaus and weight regain after stopping treatment -- and as ...

Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...